L. Claude

3.5k total citations
105 papers, 1.6k citations indexed

About

L. Claude is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, L. Claude has authored 105 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Pulmonary and Respiratory Medicine, 29 papers in Radiation and 27 papers in Surgery. Recurrent topics in L. Claude's work include Advanced Radiotherapy Techniques (29 papers), Glioma Diagnosis and Treatment (21 papers) and Lung Cancer Diagnosis and Treatment (21 papers). L. Claude is often cited by papers focused on Advanced Radiotherapy Techniques (29 papers), Glioma Diagnosis and Treatment (21 papers) and Lung Cancer Diagnosis and Treatment (21 papers). L. Claude collaborates with scholars based in France, United States and Italy. L. Claude's co-authors include C. Carrié, David Pérol, D. Arpin, Nadia N. Laack, Daniel J. Indelicato, Brian Yeh, Bree R. Eaton, L. Falchero, Rudolf Schwarz and Ralph E. Vatner and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

L. Claude

91 papers receiving 1.6k citations

Peers

Countries citing papers authored by L. Claude

Since Specialization

Citations

This map shows the geographic impact of L. Claude's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Claude with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Claude more than expected).

Fields of papers citing papers by L. Claude

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Claude. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Claude. The network helps show where L. Claude may publish in the future.

Co-authorship network of co-authors of L. Claude

This figure shows the co-authorship network connecting the top 25 collaborators of L. Claude. A scholar is included among the top collaborators of L. Claude based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Claude. L. Claude is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ostéosarcome et sarcome d’Ewing récurrents ou réfractaires – Directives françaises des groupes FSG/NETSARC et GroupOs 2025 ·Bulletin du Cancer ·Mehdi Brahmi, Maud Toulmonde, Sarah Winter, (unknown), (unknown), Nadège Corradini, Justine Gantzer, Perrine Marec‐Bérard, F. Gouin, L. Claude, Anne Ducassou, Nathalie Gaspar, Camille Tlemsani, (unknown)	0
2	Implementation of Linac-based VMAT total body irradiation technique on Elekta platform using surface-guided radiation therapy 2025 ·Physica Medica ·(unknown), (unknown), (unknown), L. Claude, I. Martel, Marie‐Claude Biston	1
3	Radiothérapie des sarcomes d’Ewing 2025 ·Bulletin du Cancer ·L. Claude, Sylvie Helfré, Nadège Corradini, Nathalie Gaspar, Pablo Berlanga, Laure Saumet, Perrine Marec‐Bérard, Cyril Lervat, M. Ropars, Sophie Piperno‐Neumann, (unknown), (unknown), Anne Ducassou, (unknown)	0
4	“Mid-P strategy” versus “internal target volume strategy in locally advanced non small cell lung cancer: Clinical results from the randomized non-comparative phase II study Mid-P 2024 ·Radiotherapy and Oncology ·L. Claude, Camille Schiffler, (unknown), (unknown), (unknown), Isabelle Martel‐Lafay, Thomas Baudier, Simon Rit, David Sarrut, (unknown)	1
5	Les essais qui changent les pratiques : le point en 2022 2022 ·Cancer/Radiothérapie ·D. Antoni, L. Claude, Anne Laprie, Antonin Lévy, Karine Peignaux, Sofía Rivera, Ulrike Schick	1
6	Toxicity and efficacy of stereotactic body radiotherapy for ultra-central lung tumours: a single institution real life experience 2021 ·British Journal of Radiology ·Élodie Guillaume, Ronan Tanguy, (unknown), L. Claude, (unknown), Coralie Moncharmont, Nicolas Magné, Isabelle Martel‐Lafay	10
7	Management of sarcomas in children, adolescents and adults: Interactions in two different age groups under the umbrellas of GSF-GETO and SFCE, with the support of the NETSARC+ network 2021 ·Bulletin du Cancer ·Emmanuelle Bompas, (unknown), (unknown), Maud Toulmonde, Perrine Marec‐Bérard, L. Claude, Françoise Ducimetière, Cyrus Chargari, Véronique Minard‐Colin, Nadège Corradini, Valérie Laurence, Sophie Piperno‐Neumann, Anne Sophie Defachelles, V. Bernier, Antoîne Italiano, Daniel Orbach, Jean‐Yves Blay, Nathalie Gaspar, Pablo Berlanga	5
8	Hypofractionated stereotactic body radiation therapy (SBRT) in pediatric patients: preliminary toxicity results of a national prospective multicenter study 2021 ·British Journal of Radiology ·(unknown), (unknown), Ellen Blanc, Anne Ducassou, A. Huchet, C. Vigneron, Alexandre Escande, S. Chapet, Julie Leseur, V. Bernier, C. Carrié, (unknown), L. Claude	8
9	Postsurgical geometrical variations of tumor bed and brainstem during photon and proton therapy for pediatric tumors of the posterior fossa: dosimetric impact and predictive factors 2021 ·Strahlentherapie und Onkologie ·Stefania Volpe, Pierre‐Yves Bondiau, L. Claude, (unknown), Laëtitia Padovani, (unknown), (unknown), (unknown), G. Baudin, C. Dejean, Daniel C. Maneval, Barbara Alicja Jereczek‐Fossa, J. Doyen	3
10	Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer center 2021 ·International Journal of Clinical Oncology ·Pierre-Étienne Heudel, Béatrice Fervers, Thierry Durand, Sylvie Chabaud, Anne‐Sophie Michallet, Frédéríc Gomez, Michel Rivoire, Thomas Bachelot, L. Claude, Catherine Chassagne‐Clément, F. Pilleul, Thomas Mognetti, (unknown), (unknown), Gisèle Chvetzoff, David Pérol, Jean‐Yves Blay	7
11	Early Toxicities After High Dose Rate Proton Therapy in Cancer Treatments 2021 ·Frontiers in Oncology ·J. Doyen, Marie‐Pierre Sunyach, Fabien Almairac, Véronique Bourg, A.O. Naghavi, (unknown), (unknown), Laëtitia Padovani, Karen Bénézery, G. Noël, Jean‐Michel Hannoun‐Lévi, Ferrán Guedea, J. Giralt, Marie Vidal, G. Baudin, (unknown), L. Claude, Pierre‐Yves Bondiau	5
12	Pattern of loco‐regional relapses and treatment in pediatric esthesioneuroblastoma: The French very rare tumors group (Fracture) contribution 2020 ·Pediatric Blood & Cancer ·Benoît Dumont, Brice Fresneau, L. Claude, Anne Sophie Defachelles, Vincent Couloigner, Stéphanie Puget, Hervé J. Brisse, Paul Fréneaux, Brigitte Lacour, Daniel Orbach	9
13	Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation 2020 ·Radiation Oncology ·(unknown), Aurélie Bertaut, (unknown), Mélanie Dore, (unknown), (unknown), L. Claude, C. Carrié, (unknown), Ronan Tanguy, Julie Blanc, Marie‐Pierre Sunyach	32
14	Adapted strategy to tumor response in childhood nasopharyngeal carcinoma: the French experience 2019 ·Strahlentherapie und Onkologie ·(unknown), Sylvie Helfré, Stéphanie Bolle, L. Claude, (unknown), Emilie Bogart, C. Vigneron, (unknown), Anne Ducassou, (unknown), (unknown), (unknown), Cécile Faure‐Conter, Brice Fresneau, Anne Sophie Defachelles, Daniel Orbach	19
15	Re-irradiation of locally recurrent pediatric intracranial ependymoma: Experience of the French society of children’s cancer 2018 ·Radiotherapy and Oncology ·(unknown), Anne Laprie, Anne Ducassou, Stéphanie Bolle, S. Supiot, Xavier Muracciole, L. Claude, S. Chapet, Bernard Coche‐Dequeant, C. Vigneron, Julie Leseur, (unknown), Jean Louis Habrand, V. Bernier	19
16	Patterns of locoregional failure in locally advanced non-small cell lung cancer treated with definitive conformal radiotherapy: Results from the Gating 2006 trial 2017 ·Radiotherapy and Oncology ·(unknown), (unknown), (unknown), Céline Ségura‐Ferlay, (unknown), (unknown), Jean‐Yves Douillard, Marc-André Mahé, L. Claude	17
17	Learning directional relative positions between mediastinal lymph node stations and organs 2014 ·Medical Physics ·David Sarrut, Simon Rit, L. Claude, (unknown), Graham Pitson, (unknown), (unknown)	4
18	Online Quality Control, Hyperfractionated Radiotherapy Alone and Reduced Boost Volume for Standard Risk Medulloblastoma: Long-Term Results of MSFOP 98 2009 ·Journal of Clinical Oncology ·C. Carrié, Jacques Grill, Dominique Figarella‐Branger, V. Bernier, Laëtitia Padovani, Jean Louis Habrand, M. Ben-Hassel, (unknown), M.-A. Mahé, Philippe Quétin, Jean Philippe Maire, Marie Baron, P. Clavère, S. Chapet, P. Maingon, Claire Alapetite, L. Claude, Anne Laprie, Sophie Dussart	49
19	Recommandations pour la pratique clinique : Standards, Options 2004 pour la prise en charge des patients atteints d’ostéosarcome, Mise à jour 2004 du chapitre radiothérapie, Validation du rapport initial : mars 1995,1 ère validation de la mise à jour du chapitre radiothérapie : décembre 1998, 2 e validation de la mise à jour du chapitre radiothérapie : septembre 2004 2005 ·Bulletin du Cancer ·L. Claude, (unknown), C. Carrié, N. Breteau, Frédérique Dijoud, Jean‐Claude Gentet, Francesco Giammarile, Jean–Louis Jouve, Michèle Kind, Perrine Marec‐Bérard, Éric Mascard, A Bataillard, Thierry Philip	4
20	[Chemoradiation for pancreatic adenocarcinoma]. 2004 ·PubMed ·(unknown), F. Mornex, L. Claude, (unknown), M. Khodri, (unknown), R. Mazeron, C Partensky	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact